Primary Device ID | 03573026161637 |
NIH Device Record Key | 73643322-44c4-4f35-9ba2-2dc5bcbb84ee |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | VIDAS® Estradiol II |
Version Model Number | 30431-01 |
Company DUNS | 276816717 |
Company Name | BIOMERIEUX SA |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | true |
Device Combination Product | false |
Single Use | false |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius |
Device Issuing Agency | Device ID |
---|---|
GS1 | 03573026161637 [Primary] |
CHP | RADIOIMMUNOASSAY, ESTRADIOL |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | New |
Device Record Status | Published |
Public Version Number | 1 |
Public Version Date | 2019-10-11 |
Device Publish Date | 2019-10-03 |
03573026256685 - ETEST® Gentamicin (GM) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026376604 - ETEST® Amoxicillin (AC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026377731 - ETEST® Flucytosine (FC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions |
03573026560690 - ETEST® Meropenem/Vaborbactam (MEV) | 2024-04-15 ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative an |
03573026475352 - ETEST® Telavancin (TLA) | 2024-04-12 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026252526 - ETEST® Cefepime (PM) | 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026253219 - Etest® TIC/CLAV-CON2 | 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026617851 - VITEK®MS | 2024-03-18 VITEK MS ready to use reagent for calibration and fine tuning of the VITEK MS instrument |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VIDAS 90812125 not registered Live/Pending |
Compound Eye Inc. 2021-07-06 |
VIDAS 86649688 4935355 Live/Registered |
bioMérieux 2015-06-03 |
VIDAS 79368562 not registered Live/Pending |
ANGEL GEORGIEV LESOV 2023-03-09 |
VIDAS 79368562 not registered Live/Pending |
SVETLA ATANASOVA LESOVA 2023-03-09 |
VIDAS 79171274 4916176 Live/Registered |
bioMérieux 2015-05-28 |
VIDAS 77640911 3849276 Live/Registered |
bioMérieux 2008-12-29 |
VIDAS 74072619 1785252 Live/Registered |
VITEK SYSTEMS, INC. 1990-06-25 |